U.S. markets close in 7 minutes

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.64-0.20 (-2.55%)
As of 3:53PM EDT. Market open.

Eton Pharmaceuticals, Inc.

21925 West Field Parkway
Suite 235
Deer Park, IL 60010-7208
United States
847 787 7361

Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Mr. Sean E. BrynjelsenPres, CEO & Director705.93kN/A1972
Mr. W. Wilson Troutman CPACFO, Treasurer & Sec.396.48kN/A1954
Mr. Paul SticklerSr. VP of Sales & MarketingN/AN/AN/A
Ms. Bharathi DevarakondaSr. VP of Regulatory Affairs & Product Devel.N/AN/AN/A
Ms. Ingrid HoosSr. VP of Regulatory AffairsN/AN/AN/A
Mr. Scott GrossenbachVP of Sales & MarketingN/AN/AN/A
Mr. David Krempa CFAVP of Bus. Devel.N/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. It also develops ET-105, a lamotrigine for oral suspension; DS-300, a cysteine injection; DS-100, a dehydrated alcohol injection; ET-104, a zonisamide oral suspension; ET-101, a topiramate oral suspension; and ET-203, an ephedrine ready-to-use injection. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Corporate Governance

Eton Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.